Leichtes Magnesiumoxid Magnesium-Ionen Al

Magnesium, the active ingredient in Leichtes Magnesiumoxid Magnesium-Ionen Al, is a mineral supplement presented as an oral product for oral use. It is used to address magnesium deficiency and supports normal neuromuscular function in adults and children when indicated.

GNH USA supplies Leichtes Magnesiumoxid Magnesium-Ionen Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Leichtes Magnesiumoxid Magnesium-Ionen Al is a magnesium supplement that helps correct low magnesium levels and related conditions. - Magnesium deficiency: restores normal serum magnesium concentrations. - Hypomagnesemia: supports recovery of deficient magnesium status. - Muscle cramps associated with low magnesium: reduces frequency and intensity of cramps.

Magnesium supplementation may be associated with several adverse reactions.

Common Side Effects: - Diarrhea: loose stools occurring after intake. - Abdominal discomfort: mild stomach pain or cramping. - Nausea: feeling of queasiness. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium leading to cardiac arrhythmia. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Hypotension: marked drop in blood pressure.

When using Leichtes Magnesiumoxid Magnesium-Ionen Al, consider the following precautions. - Renal function assessment: evaluate kidney performance before initiation. - Serum magnesium monitoring: check levels periodically during therapy. - Cardiac conduction caution: avoid in patients with heart block without supervision. - Hypersensitivity check: discontinue if allergic signs appear. - Elderly dose adjustment: start with lower doses in older adults. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Magnesium can affect the absorption and activity of several medicines.

Major Interactions (Avoid): - Tetracycline antibiotics: reduced antibiotic absorption. - Fluoroquinolone antibiotics: decreased antimicrobial efficacy. - Bisphosphonates: impaired bone‑protective drug uptake.

Moderate Interactions (Monitor Closely): - ACE inhibitors: potential additive blood‑pressure lowering effect. - Loop diuretics: may increase risk of hypomagnesemia. - Proton pump inhibitors: possible reduction in magnesium absorption over long term.